Editorial & Opinion
أعرض في EDS

Reply to Patel et al. 'Mucinous differentiation of rectal cancers: does it really impact oncological outcomes?'

التفاصيل البيبلوغرافية
العنوان: Reply to Patel et al. 'Mucinous differentiation of rectal cancers: does it really impact oncological outcomes?'
المؤلفون: Koëter T; Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands., Stijns RCH; Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands., van Koeverden S; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Hugen N; Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands., van der Heijden JAG; Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands., Nederend J; Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands., van Zwam PH; Department of Pathology, PAMM Laboratory for Pathology and Medical Microbiology, Eindhoven, The Netherlands., Nagtegaal ID; Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands., Verheij M; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Rutten HJT; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., de Wilt JHW; Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands.
المصدر: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland [Colorectal Dis] 2021 Oct; Vol. 23 (10), pp. 2775-2776. Date of Electronic Publication: 2021 Jul 26.
نوع المنشور: Letter; Comment
اللغة: English
بيانات الدورية: Publisher: Blackwell Science Ltd Country of Publication: England NLM ID: 100883611 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1318 (Electronic) Linking ISSN: 14628910 NLM ISO Abbreviation: Colorectal Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Oxford, UK : Blackwell Science Ltd.,
مواضيع طبية MeSH: Adenocarcinoma, Mucinous* , Rectal Neoplasms*/surgery, Humans
التعليقات: Comment on: Colorectal Dis. 2021 Sep;23(9):2341-2347. (PMID: 34051043)
Comment on: Colorectal Dis. 2021 Oct;23(10):2774-2775. (PMID: 34273221)
References: Koeter T, Stijns RCH, van Koeverden S, Hugen N, van der Heijden JAG, Nederend J, et al. Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy. Colorectal Dis. 2021. https://doi.org/10.1111/codi.15760.
Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018;28(4):1465-75.
Bernier L, Balyasnikova S, Tait D, Brown G. Watch-and-wait as a therapeutic strategy in rectal cancer. Curr Colorectal Cancer Rep. 2018;14(2):37-55.
Hugen N, Verhoeven RH, Lemmens VE, van Aart CJ, Elferink MA, Radema SA, et al. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor. Int J Cancer. 2015;136(2):333-9.
Borger ME, Gosens MJ, Jeuken JW, van Kempen LC, van de Velde CJ, van Krieken JH, et al. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol. 2007;212(3):278-86.
Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479-82.
Oberholzer K, Menig M, Kreft A, Schneider A, Junginger T, Heintz A, et al. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys. 2012;82(2):842-8.
Simha V, Kapoor R, Gupta R, Bahl A, Nada R. Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation? J Gastrointest Oncol. 2014;5(4):276-9.
Rutten H, den Dulk M, Lemmens V, Nieuwenhuijzen G, Krijnen P, Jansen-Landheer M, et al. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery. Eur J Cancer. 2007;43(15):2295-300.
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638-46.
Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29-42.
Conroy T, Bosset JF, Etienne PL, Rio E, Francois E, Mesgouez-Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702-15.
تواريخ الأحداث: Date Created: 20210717 Date Completed: 20211029 Latest Revision: 20211029
رمز التحديث: 20240628
DOI: 10.1111/codi.15821
PMID: 34273235
قاعدة البيانات: MEDLINE
الوصف
تدمد:1463-1318
DOI:10.1111/codi.15821